Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Colchicine: Now and What’s Next?

National Lipid Association

C. Ballantyne

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Peripheral Arterial Disease: How To Prevent? When To Diagnose? How T…

Piedmont Heart Institute

A. Klein

My ALI Algorithm: Now vs. Later

NY Endovascular Summit

A. Dua

Plant-based Diets for Improving Lipids

National Lipid Association

K. Williams

Role of Lipoprotein (a) in Coronary Disease: An Emerging Novel Target

Practical Ways to Achieve Targets in Diabetes Care

S. Nissen

Aspirin for the Primary Prevention of Cardiovascular Disease: What C…

Houston Methodist DeBakey Heart and Vascular Center

M. Miedema

Classification Systems in CLTI: Are They Relevant?

NY Endovascular Summit

R. Lookstein

CLTI Expert Forum: Case-Based Review - Problematic Calcium

NY Endovascular Summit

V. Kapur

Management of CAD in PAD Patients: Reducing Adverse Cardiac Events a…

Transformative Endovascular Decisions Conference

C. Zarins

New Medications for Heart Failure: SGLT2 Inhibitors and Vericiguat. …

American Heart & Vascular Institute

M. Kittleson

The Rearfoot Fusion Versus Midfoot Beaming for Charcot MidFoot Defor…

NY Endovascular Summit

J. Godoy

BEST CLI Debate: Endovascular Will Still Be First Line Treatment & P…

Transformative Endovascular Decisions Conference

P. Soukas

Diabetes and Heart Failure: The New Frontier

Mount Sinai Advanced Innovations in Heart Failure Symposium 2019

E. Braunwald

Targeting Inflammation to Prevent Cardiovascular Disease - Ready for…

National Lipid Association

M. Garshick

Cardiometabolic Therapies: GLP-1 RAs and SGLT-2i

Piedmont Heart Institute

J. Burkle